Trademark: 90062152
Status Date
Monday, February 5, 2024
Filing Date
Monday, July 20, 2020
Published for Opposition
Tuesday, May 25, 2021
5 Pharmaceutical preparations and therapeutic agents for modulating the immune system; pharmaceutical and therapeutic agents for use as immunotherapies; pharmaceutical preparations and therapeutic agents for selectively suppressing immune cells to tolerize for specific antigens; pharmaceutical preparations and therapeutic agents for inducing immune tolerance
44 Health care services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; health assessment services; health monitoring services, namely, monitoring immune status of individuals for diagnostic and treatment purposes; advisory services relating to health; providing information in the field of health
42 Medical and clinical research and development for others in the field of immunology; medical and clinical research and development for others in the field of immunotherapies; medical and clinical research and development for others in the field of nucleic acid-based technology for selectively suppressing immune cells to tolerize for specific antigens; medical and clinical research and development for others in the field of nucleic acid-based technology for inducing immune tolerance; consulting services in the field of immunotherapy research, transplanted tissues and organs research, and drug discovery and development; medical laboratory research; scientific research
APOPTOTIC DNA IMMUNOTHERAPY TXT
Feb 6, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 5, 2024
Sou Extension 5 Granted
Jan 19, 2024
Sou Extension 5 Filed
Feb 5, 2024
Case Assigned To Intent To Use Paralegal
Jan 19, 2024
Sou Teas Extension Received
Jul 19, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 17, 2023
Sou Extension 4 Granted
Jul 17, 2023
Sou Extension 4 Filed
Jul 17, 2023
Sou Teas Extension Received
Jan 19, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 17, 2023
Sou Extension 3 Granted
Jan 17, 2023
Sou Extension 3 Filed
Jan 17, 2023
Sou Teas Extension Received
Jul 20, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 18, 2022
Sou Extension 2 Granted
Jul 18, 2022
Sou Extension 2 Filed
Jul 18, 2022
Sou Teas Extension Received
Mar 23, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 23, 2022
Teas Change Of Correspondence Received
Mar 23, 2022
Teas Change Of Owner Address Received
Jan 22, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 20, 2022
Sou Extension 1 Granted
Jan 20, 2022
Sou Extension 1 Filed
Jan 20, 2022
Sou Teas Extension Received
Sep 22, 2021
Automatic Update Of Assignment Of Ownership
Jul 20, 2021
Noa E-Mailed - Sou Required From Applicant
May 25, 2021
Official Gazette Publication Confirmation E-Mailed
May 25, 2021
Published For Opposition
May 5, 2021
Notification Of Notice Of Publication E-Mailed
Apr 16, 2021
Approved For Pub - Principal Register
Apr 14, 2021
Examiner's Amendment Entered
Apr 14, 2021
Notification Of Examiners Amendment E-Mailed
Apr 14, 2021
Examiners Amendment E-Mailed
Apr 14, 2021
Examiners Amendment -Written
Mar 4, 2021
Teas/Email Correspondence Entered
Mar 3, 2021
Correspondence Received In Law Office
Mar 3, 2021
Teas Response To Office Action Received
Nov 16, 2020
Notification Of Non-Final Action E-Mailed
Nov 16, 2020
Non-Final Action E-Mailed
Nov 16, 2020
Non-Final Action Written
Nov 3, 2020
Assigned To Examiner
Aug 18, 2020
New Application Office Supplied Data Entered
Jul 23, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
